# Type 2 Diabetes Haptoglobin Phenotype and Vitamin E

> **NCT01113671** · PHASE2,PHASE3 · COMPLETED · sponsor: **Technion, Israel Institute of Technology** · enrollment: 90 (estimated)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** Vitamin E (d-alpha-tocopheryl acetate)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01113671
- **Lead sponsor:** Technion, Israel Institute of Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-07
- **Final completion:** 2011-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2011-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01113671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01113671, "Type 2 Diabetes Haptoglobin Phenotype and Vitamin E". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01113671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*